Spaulding Clinical Research Reports Record Revenue for 2012


February 4, 2013 – West Bend, Wisconsin, USA   Today, Spaulding Clinical Research, a change agent in the clinical research and medical device industries, announces that the company tripled its fiscal yearly revenues for the period ending December 31st, 2012. 

“Our customer retention and the ability to attract new Sponsors demonstrate Spaulding Clinical’s commitment to delivering the highest-quality, on-time study results for every study.  This is also reflected in our high net promoter score,” states Daniel Selness, General Manager and Sr. Vice President of Clinical Research at Spaulding.

Randy Spaulding, founder and CEO of Spaulding Clinical states, “Our vision for speed and results has been demonstrated again this year by more sponsors benefiting from the value of our customized Clinical Pharmacology electronic data capture (EDC) solution.   With bi-directional interfaces to clinical lab results, bedside devices and telemetry, all phase I study data seamlessly transfer into the Medidata Rave® EDC or any requested clinical data management system.  Spaulding’s value to clients is realized by not only saving time but also through the virtual elimination of data transcription errors.”

Spaulding Clinical also reported substantial growth in their Centralized Cardiac Safety services as sponsors and global investigators recognize the advantages of the company’s cloud-based webECGTM diagnostic 12-lead ECG management solution, utilizing Spaulding’s purpose-built Electrocardiograph.  The solution provides up to 5 minutes of ECG data, saving clients the cost of triplicate readings. 

“In addition, sponsors are realizing that our solution is a cost effective alternative to the non-centralized investigator grant approach, “states Daniel Selness, General Manager and Sr. Vice President of Clinical Research at Spaulding.  “We also see future growth opportunities in long-term Pharmacovigilance monitoring and safety surveillance.”

Spaulding Clinical publishes their metrics at www.spauldingclinical.com .

About Spaulding Clinical Research, LLC

Spaulding Clinical Research, LLC ( www.spauldingclinical.com ) a change agent in the clinical research and medical device industries, is focused on driving perpetual value for their clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

Spaulding Clinical Research operates a 105-bed clinical pharmacology unit with 96, 12-lead ECG, telemetry beds in West Bend, Wisconsin, USA. The facility is paperless, using a customized Phase I Electronic Data Capture system with bi-directional interfaces to clinical lab, bedside devices and telemetry. Spaulding Biometrics provides full-service biostatistics, data management and medical writing services.

As a Phase I-IV centralized cardiac safety provider, Spaulding Clinical offers project management, expert cardiologist ECG over-read and a complete suite of state-of-the-art equipment provisioning, including the Spaulding webECGTMdiagnostic 12-lead ECG Management Solution with the purpose-built Spaulding Model 1000iQ Electrocardiograph.

Spaulding Clinical Media Contact
Kathy Forde
Sr. Director of Marketing
Tel: (414) 303-1912
Email: kathy.forde@spauldingclinical.com

Tags:

About Us

Spaulding Clinical Research, LLC (www.spauldingclinical.com) provides Clinical Pharmacology, Cardiac Core Lab clinical research services, and is a medical device manufacturer. Spaulding Clinical operates a 155-bed clinical pharmacology unit with 96-beds of telemetry in West Bend, Wisconsin, USA. The facility is paperless, with a Phase I Electronic Data Capture system and bi-directional interfaces to safety lab, bedside devices and telemetry. As a Phase I-IV Core ECG Laboratory provider, Spaulding Clinical offers the complete suite of equipment provisioning and electrocardiograph over-reading services with state-of-the-art technologies, including the proprietary Spaulding iQ Electrocardiograph, and expertly-cardiologists and project managers